On Friday, Chinese AI firm DeepSeek released a preview of V4, its long-awaited new flagship model. Notably, the model can process much longer prompts than its last generation, thanks to a new design that helps it handle large amounts of text more efficiently. Like DeepSeek’s previous models, V4 is open source, meaning it is available for anyone to download, use, and modify.

V4 marks DeepSeek’s most significant release since R1, the reasoning model it launched in January 2025. R1, which was trained on limited computing resources, stunned the global AI industry with its strong performance and efficiency, turning DeepSeek from a little-known research team into China’s best-known AI company almost overnight. It also helped set off a wave of open-weight model releases from other Chinese AI firms. 

DeepSeek has kept a relatively low profile since then—but earlier this month, it effectively teased V4’s release when it added “expert” and “flash” modes to the online version of its model, prompting speculation that the updates were tied to a bigger upcoming release.

While the company has become a powerful symbol of China’s AI ambitions, its big return to cutting-edge frontier models comes after months of scrutiny—including major personnel departures, delays to previous model launches, and growing scrutiny from both the US and Chinese governments. 

So, will V4 shake the AI field the way R1 did? Almost certainly not, but here are three big reasons why this release matters.

1. It breaks new ground for an open-source model.

As with R1 before it, DeepSeek claims that V4’s performance rivals the best models available at a fraction of the price. This is great news for developers and for companies using the tech, because it means they can access frontier AI capabilities on their own terms, and without worrying about skyrocketing costs.

The new model comes in two versions, both of which are available on DeepSeek’s website and in its app, with API access also open to developers. V4-Pro is a larger model built for coding and complex agent tasks, and V4-Flash is a smaller version designed to be faster and cheaper to run. Both versions offer reasoning modes, in which the model can carefully parse a user’s prompt and show each step as it works through the problem.

For V4-Pro, DeepSeek charges $1.74 per million input tokens and $3.48 per million output tokens, a fraction of the cost of comparable models from OpenAI and Anthropic. V4-Flash is even cheaper, at about $0.14 per million input tokens and about $0.28 per million output tokens, making it one of the cheapest top-tier models available. This would make it a very appealing model to build applications on.

In terms of performance, V4 is, perhaps unsurprisingly, a huge jump from R1—and it seems to be a strong alternative to just about all the latest big AI models. On the major benchmarks, according to results shared by the company, DeepSeek V4-Pro competes with leading closed-source models, matching the performance of Anthropic’s Claude-Opus-4.6, OpenAI’s GPT-5.4, and Google’s Gemini-3.1. And compared to other open-source models, such as Alibaba’s Qwen-3.5 or Z.ai’s GLM-5.1, DeepSeek V4 exceeds them all on coding, math, and STEM problems, making it one of the strongest open-source models ever released. 

DeepSeek also says that V4-Pro now ranks among the strongest open-source models on benchmarks for agentic coding tasks and performs well on other tests that measure ability to carry out multistep problems. Its writing ability and world knowledge also lead the field, according to benchmarking results shared by the company. 

In a technical report released alongside the model, DeepSeek shared results from an internal survey of 85 experienced developers: More than 90% included V4-Pro among their top model choices for coding tasks.

DeepSeek says it has specifically optimized V4 for popular agent frameworks such as Claude Code, OpenClaw, and CodeBuddy.

2. It delivers on a new approach to memory efficiency.

One of the key innovations of V4 is its long context window—the amount of text the model can process at once. Both versions can handle 1 million tokens, which is large enough to fit all three volumes of The Lord of the Rings and The Hobbit combined. The company says this context window size is now the default across all DeepSeek services and it matches what is offered by cutting-edge versions of models like Gemini and Claude. 

But it’s important to know not just that DeepSeek has made this leap, but how it did so. V4 makes significant architectural changes to the company’s former models—especially in the attention mechanism, which is the feature of AI models that helps them understand each part of a prompt in relation to the rest. As the prompt text gets longer, these comparisons become much more costly, making attention one of the main bottlenecks for long-context models.

DeepSeek’s innovation was to make the model more selective about what it pays attention to. Instead of treating all earlier text as equally important, V4 compresses older information and focuses on the parts most likely to matter in the present moment, while still keeping nearby text in full so it does not miss important details. 

DeepSeek says this sharply reduces the cost of using long context. In a 1-million-token context, V4-Pro uses only 27% of the computing power required by its previous model, V3.2, while cutting memory use to 10%. The reduction in V4-Flash is even larger, using just 10% of the computing power and 7% of the memory. In practice, this could make it cheaper to build tools that need to work across huge amounts of material, such as an AI coding assistant that can read an entire codebase or a research agent that can analyze a long archive of documents without constantly forgetting what came before.

DeepSeek’s interest in long context windows didn’t start with V4. Over the past year and a half, the company has quietly published a series of papers on how AI models “remember” information, experimenting with compression and mathematical techniques to extend what AI models could realistically handle.

3. It marks the first steps on the hard road away from Nvidia.

V4 is DeepSeek’s first model optimized for domestic Chinese chips, such as Huawei’s Ascend—a move that has turned the launch into something of a test of whether China’s homegrown AI industry can begin to loosen its dependence on US chip giant Nvidia. 

This was largely expected, since The Information reported earlier this month that DeepSeek did not give American chipmakers like Nvidia and AMD early access to V4, though prerelease access is common to allow chipmakers to optimize support of the new model ahead of a launch. Instead, the company reportedly gave early access only to Chinese chipmakers. 

On Friday, Huawei said its Ascend supernode products, based on the Ascend 950 series, would support DeepSeek V4. This means that companies and individuals who want to run their own modified version of Deepseek V4 will be able to use Huawei chips easily.

Reuters previously reported that Chinese government officials recommended that DeepSeek integrate Huawei chips in its training process. And this pressure fits a broader pattern in China’s industrial policy: Strategic sectors are often pushed, and sometimes effectively required, to align with national self-reliance goals. But there’s a particular urgency when it comes to AI. Since 2022, US export controls have cut Chinese firms off from Nvidia’s most powerful chips, and they later also restricted access to downgraded China-market versions. Beijing’s response has been to accelerate the push for a domestic AI stack, from chips to software frameworks to data centers.

Chinese authorities have reportedly been pushing data centers and public computing projects to use more domestic chips, including through reported bans on foreign-made chips, sourcing quotas, and requirements to pair Nvidia chips with Chinese alternatives from companies such as Huawei and Cambricon. 

Still, replacing Nvidia is not as simple as swapping one chip for another. Nvidia’s advantage lies not only in its chips, but in the software ecosystem developers have spent years building around them. Moving to Huawei’s Ascend chips means adapting model code, rebuilding tools, and proving that systems built around those chips are stable enough for serious use.

To be clear, DeepSeek does not appear to have fully moved beyond Nvidia. The company’s technical report reveals that it is using Chinese chips to run the model for inference, or when someone asks the model to complete a task. But Liu Zhiyuan, a computer science professor at Tsinghua University, told MIT Technology Review that DeepSeek appears to have adapted only part of V4’s training process for Chinese chips. The report does not say whether some key long-context features were adapted to domestic chips, so Liu says V4 may still have been trained mainly on Nvidia chips. Multiple sources who spoke on the condition of anonymity, due to political sensitivity around these issues, told MIT Technology Review that Chinese chips still don’t perform as well as Nvidia chips but are better suited for inference than training.

DeepSeek is also tying the future costs of V4 to this hardware shift. The company says V4-Pro prices could fall significantly after Huawei’s Ascend 950 supernodes begin shipping at scale in the second half of this year. 

If that works, V4 could be an early sign that China is successfully building a parallel AI infrastructure.

Read more

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.

We’re in a new era of AI-driven scams

When ChatGPT was released in late 2022, it showed how easily generative AI could create human-like text. This quickly caught the eye of cybercriminals, who began using LLMs to compose malicious emails. Since then, they’ve adopted AI for everything from turbocharged phishing and hyperrealistic deepfakes to automated vulnerability scans.

Many organizations are now struggling to cope with the sheer volume of cyberattacks. AI is making them faster, cheaper, and easier to carry out, a problem set to worsen as more cybercriminals adopt these tools—and their capabilities improve. Read the full story on how AI is reshaping cybercrime.

—Rhiannon Williams

“Supercharged scams” is one of the 10 Things That Matter in AI Right Now, our essential guide to what’s really worth your attention in the field.

Subscribers can watch an exclusive roundtable unveiling the technologies and trends on the list, with analysis from MIT Technology Review’s AI reporter Grace Huckins and executive editors Amy Nordrum and Niall Firth.

Healthcare AI is here. We don’t know if it actually helps patients.

Doctors are using AI to help them with notetaking. AI-based tools are trawling through patient records, flagging people who may require certain support or treatments. They are also used to interpret medical exam results and X-rays.

A growing number of studies suggest that many of these tools can deliver accurate results. But there’s a bigger question here: Does using them actually translate into better health outcomes for patients? We don’t yet have a good answer—here’s why.

—Jessica Hamzelou

The story is from The Checkup, our weekly newsletter that gives you the latest from the worlds of health and biotech. Sign up to receive it in your inbox every Thursday.

The must-reads

I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.

1 DeepSeek has unveiled its long-awaited new AI model
The Chinese company has just launched preview versions of DeepSeek-V4. (CNN)
+It says V4 is the most powerful open-source platform. (Bloomberg $)
+ And rivals top closed-source models from OpenAI and DeepMind. (SCMP)
+ The model is adapted for Huawei chip technology. (Reuters $)

2 More countries are curbing children’s social media access
Norway is set to enforce the latest ban. (Reuters $)
+ The Philippines could follow soon. (Bloomberg $)
+ Americans are pushing to get AI out of schools. (The New Yorker)

3 The US has accused China of mass AI theft as tensions rise
A White House memo claims Chinese firms are exploiting American models. (BBC)
+ Beijing calls the accusations “slander.” (Ars Technica)

4 OpenAI set itself apart from Anthropic by widely releasing its new model
It’s releasing GPT-5.5 to all ChatGPT users, despite cybersecurity concerns. (NYT $)
+ OpenAI says the new model is better at coding and more efficient. (The Verge)

5 Meta is cutting 10% of jobs to offset AI spending
Roughly 8,000 layoffs are set to be announced on May 20. (QZ)
+ Anti-AI protests are growing. (MIT Technology Review)

6 Palantir is facing a backlash from employees
Thanks to its work with ICE and the Trump administration. (Wired $)
+ Surveillance tech is reshaping the fight for privacy. (MIT Technology Review)

7 The era of free access to advanced AI is coming to an end
AI labs are under mounting pressure to start turning profits. (The Verge)

8 Elon Musk’s feud with Sam Altman is heading to court 
The case has already revealed several unflattering secrets. (WP $)

9 A new movement is encouraging people to ditch their smartphones for a month
“Month Offline” is like a Dry January for smartphones. (The Atlantic)

10 Spotify has revealed its most-streamed music of the last 20 years
Featuring Taylor Swift, Bad Bunny, and The Weeknd. (Gizmodo

Quote of the day

“We want a childhood where children get to be children. Play, friendships, and everyday life must not be taken over by algorithms and screens.” 

—Norwegian Prime Minister Jonas Gahr Store announces age restrictions for social media.

One More Thing

""
NASA/JPL-CALTECH VIA WIKIMEDIA COMMONS; CRAFT NASA/JPL-CALTECH/SWRI/MSSS; IMAGE PROCESSING: KEVIN M. GILL


The search for extraterrestrial life is targeting Jupiter’s icy moon Europa

As astronomers have discovered more about Europa over the past few decades, Jupiter’s fourth-largest moon has excited planetary scientists interested in the geophysics of alien worlds.

 All that water and energy—and hints of elements essential for building organic molecules —point to an extraordinary possibility. In the depths of its ocean, or perhaps crowded in subsurface lakes or below icy surface vents, Jupiter’s big, bright moon could host life. 

To find further evidence, NASA is now searching for signs of alien existence on Europa. Read the full story on the mission.


—Stephen Ornes

We can still have nice things

A place for comfort, fun and distraction to brighten up your day. (Got any ideas? Drop me a line.)

+ Here’s a fun look at the secret collaborations of pop history.
+ Meet the mannequins showing how the “ideal” body has evolved.
+ A photographer has cataloged all 12,795 objects in her home into an archive of a life.
+ Slime molds are unexpectedly beautiful when viewed through these high-detail macro shots.

Read more

I don’t need to tell you that AI is everywhere.

Or that it is being used, increasingly, in hospitals. Doctors are using AI to help them with notetaking. AI-based tools are trawling through patient records, flagging people who may require certain support or treatments. They are also used to interpret medical exam results and X-rays.

A growing number of studies suggest that many of these tools can deliver accurate results. But there’s a bigger question here: Does using them actually translate into better health outcomes for patients?

We don’t yet have a good answer.

That’s what Jenna Wiens, a computer scientist at the University of Michigan, and Anna Goldenberg of the University of Toronto, argue in a paper published in the journal Nature Medicine this week.

Wiens tells me she has spent years investigating how AI might benefit health care. For the first decade of her career she tried to pitch the technology to clinicians. Over the last few years, she says, it’s as though “a switch flipped.” Health-care providers not only appear much more interested in the promise of these technologies, they have also begun rapidly deploying them.

The problem is that many providers aren’t rigorously assessing how well they actually work.

Take “ambient AI” tools, for example. Also known as AI scribes, they “listen” to conversations between doctors and patients, then transcribe and summarize them. Multiple tools are available, and they are already being widely adopted by health-care providers.

A few months ago, a staffer at a major New York medical center who develops AI tools for doctors told me that, anecdotally, medics are “overjoyed” by the technology—it allows them to focus all their attention on their patients during appointments, and it saves them from a lot of time-consuming paperwork. Early studies support these anecdotes and suggest that the tools can reduce clinician burnout.

That’s all well and good. But what about patient health outcomes? “[Researchers] have evaluated provider or clinician and patient satisfaction, but not really how these tools are affecting clinical decision-making,” says Wiens. “We just don’t know.”

The same holds true for other AI-based technologies used in health-care settings. Some are used to predict patients’ health trajectories, others to recommend treatments. They are designed to make health care more effective and efficient.

But even a tool that is “accurate” won’t necessarily improve health outcomes. AI might speed up the interpretation of a chest X-ray, for example. But how much will a doctor rely on its analysis? How will that tool affect the way a doctor interacts with patients or recommends treatment? And ultimately: What will this mean for those patients?

The answers to those questions might vary between hospitals or departments and could depend on clinical workflows, says Wiens. They might also differ between doctors at various stages of their careers.

Take the AI scribes, as another example. Some research on AI use in education suggests that such tools can impact the way people cognitively process information. Could they affect the way a doctor processes a patient’s information? Will the tools affect the way medical students think about patient data in a way that impacts care? These questions need to be explored, says Wiens. “We like things that save us time, but we have to think about the unintended consequences of this,” she says.

In a study published in January 2025, Paige Nong at the University of Minnesota and her colleagues found that around 65% of US hospitals used AI-assisted predictive tools. Only two-thirds of those hospitals evaluated their accuracy. Even fewer assessed them for bias.

The number of hospitals using these tools has probably increased since then, says Wiens. Those hospitals, or entities other than the companies developing the tools, need to evaluate how much they help in specific settings. There’s a possibility that they could leave patients worse off, although it’s more likely that AI tools just aren’t as beneficial as health-care providers might assume they are, says Wiens.

“I do believe in the potential of AI to really improve clinical care,” says Wiens, who stresses that she doesn’t want to stop the adoption of AI tools in health care. She just wants more information about how they are affecting people. “I have to believe that in the future it’s not all AI or no AI,” she says. “It’s somewhere in between.”

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.
 

Read more
1 137 138 139 140 141 3,275